Roger Bastow

Statistics

Publications

Citations

236

H-Index

Active since

1967

Affiliations

Keele University(Current)

Royal Hallamshire Hospital

University of Warwick

Queen Mary University of London

University of Leeds

Roger Bastow is an author at Keele University specializing in secondary progressive multiple sclerosis treatment, neuroprotection, and multiple sclerosis neuroprotection.

ORCID

Publications per year

1967–2020

Publications

Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial

Jeremy Chataway, Floriana De Angelis, Peter Connick et al. · The Lancet Neurology · 2020 · 130 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis

Peter Connick, Floriana De Angelis, Richard Parker et al. · BMJ Open · 2018 · 56 citations · Full text

Medicine, Neurology, Pharmacology +17

Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT

Floriana De Angelis, Peter Connick, Richard Parker et al. · Efficacy and Mechanism Evaluation · 2020 · 27 citations · Full text

Medicine, Neurology, Pharmacology +15

A note on spectrophotometric methods for the determination of norethynodrel and mestranol in tablets

Roger Bastow · Journal of Pharmacy and Pharmacology · 1967 · 23 citations

Natural Sciences, Pharmaceutical Analysis, Pharmacology +11

1–4 of 4